Header

UZH-Logo

Maintenance Infos

Two Year Outcomes of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially for Neovascular Age-Related Macular Degeneration


Barthelmes, Daniel; Nguyen, Vuong; Daien, Vincent; Campain, Anna; Walton, Richard; Guymer, Robyn; Morlet, Nigel; Hunyor, Alex P; Essex, Rohan W; Arnold, Jennifer J; Gillies, Mark C; Fight Retinal Blindness Study Group (2018). Two Year Outcomes of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially for Neovascular Age-Related Macular Degeneration. Retina, 38(1):20-28.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Downloads

98 downloads since deposited on 13 Oct 2017
98 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Ophthalmology Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2018
Deposited On:13 Oct 2017 06:50
Last Modified:20 Feb 2018 08:53
Publisher:Lippincott Williams & Wilkins
ISSN:0275-004X
OA Status:Green
Publisher DOI:https://doi.org/10.1097/IAE.0000000000001496
PubMed ID:28145976

Download

Download PDF  'Two Year Outcomes of "Treat And Extend" Intravitreal Therapy Using Aflibercept Preferentially for Neovascular Age-Related Macular Degeneration'.
Preview
Filetype: PDF
Size: 295kB
View at publisher